Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Introduction
  • Published:

Introduction to the POWER-UP supplement

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 2011; 365: 1959–1968.

    Article  CAS  Google Scholar 

  2. Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365: 1969–1979.

    Article  CAS  Google Scholar 

  3. Bennett GG, Warner ET, Glasgow RE, Askew S, Goldman J, Ritzwoller DP et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med 2012; 172: 565–574.

    Article  Google Scholar 

  4. Wadden TA, Volger S, Sarwer DB, Tsai AG, Berkowitz RI, Diewald L et al. Managing obesity in primary care practice: An overview with perspective from the POWER-UP study. Int J Obes 2013; 37: S3–S11.

    Article  Google Scholar 

  5. Volger S, Wadden TA, Sarwer DB, Moore RH, Chittams J, Diewald L et al. Changes in eating, physical activity and related behaviors in a primary-care-based weight loss intervention. Int J Obes 2013; 37: S12–S18.

    Article  Google Scholar 

  6. Vetter ML, Wadden TA, Chittams J, Diewald L, Panigrahi E, Volger S et al. Effect of lifestyle intervention on cardiometabolic risk factors: results from the POWER-UP Trial. Int J Obes 2013; 37: S19–S24.

    Article  Google Scholar 

  7. Sarwer DB, Moore RH, Diewald LK, Chittams J, Berkowitz RI, Vetter Mv et al. The impact of a primary care-based weight loss intervention on quality of life. Int J Obes 2013; 37: S25–S30.

    Article  Google Scholar 

  8. Tsai AG, Wadden TA, Volger S, Sarwer DB, Vetter M, Kumanyika S et al. Cost-effectiveness of a primary care intervention to treat obesity. Int J Obes 2013; 37: S31–S37.

    Article  Google Scholar 

  9. Vetter ML, Wadden TA, Vinnard C, Moore RH, Khan Z, Volger S et al. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int J Obes 2013; 37: S38–S43.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the health-care providers who delivered the POWER-UP intervention at the six primary care sites and, who with the study’s investigators and research coordinators, comprised the POWER-UP Research Group. GlaxoSmithKline and Unilver are acknowledged for providing orlistat and SlimFast products, respectively. We also thank colleagues from National Institutes of Health/National Heart, Lung, and Blood Institute who contributed to the design and administration of the three POWER trials. We particularly wish to acknowledge Dr Barbara Wells, the Project Officer for the POWER trials, who contributed in innumerable ways, as a colleague and advisor, to the successful completion of this research. We also thank her colleagues, Drs Catherine Stoney (Executive Secretary), Jungnam Joo, Peter Kaufmann and Caye Loria. We are pleased to acknowledge members of the Data, Safety, and Monitoring Board who oversaw the conduct of the study. They include Drs David Goff (chair), Robert Kushner, Gbenga Ogedegbe, Amelie Ramirez, Nathan Stimson and Barbara Tilley. We also acknowledge Drs Hsin-Chieh Yeh (Chair) and Gerald Jerome from the Resource Coordinating Unit at Johns Hopkins University. We thank Dr Delia West for sharing the weight loss maintenance protocol developed by the PRIDE Research Group. Electronic copies of the training and intervention materials may be obtained from the first author. This supplement is dedicated to the memory of our dear friend and colleague, Dr Thomas Ten Have. This research was supported by grants U01-HL087072 from the National Heart, Lung and Blood Institute and K24-DK065018 from the National Institute of Diabetes and Digestive and Kidney Disease.

This article is published as part of a supplement, sponsored by the Center for Weight and Eating Disorders—University of Pennsylvania.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T A Wadden.

Ethics declarations

Competing interests

TW serves on the advisory boards of Novo Nordisk and Orexigen Therapeutics, which are developing weight loss medications, as well as of Alere and the Cardiometabolic Support Network, which provide behavioral weight loss programs. TW has also served as a consultant for Boehringer Ingelheim, and has received grant support from the National Institutes of Health (NIH/NIDDK and NIH/NHLBI). DS discloses relationships with the following companies: Allergan, BariMD, BaroNova, Enteromedics and Galderma. DS has also received grant support from the National Institutes of Health (NIH). The remaining authors declare no conflict of interest.

Appendix

Appendix

POWER-UP Research Group: Investigators and Research Coordinators

Academic investigators at the Perelman School of Medicine at the University of Pennsylvania were Thomas A Wadden, PhD (principal investigator); David B Sarwer, PhD (co-principal investigator); Robert I Berkowitz, MD; Jesse Chittams, MS; Lisa Diewald, MS, RD; Shiriki Kumanyika, PhD; Renee Moore, PhD; Kathryn Schmitz, PhD; Adam G Tsai, MD MSCE; Marion Vetter, MD; and Sheri Volger, MS, RD.

Research coordinators at the University of Pennsylvania were Caroline H Moran, BA; Jeffrey Derbas, BS; Megan Dougherty, BS; Zahra Khan, BA; Jeffrey Lavenberg, MA; Eva Panigrahi, MA; Joanna Evans, BA; Ilana Schriftman, BA; Dana Tioxon; Victoria Webb, BA; and Catherine Williams-Smith, BS.

POWER-UP Research Group: participating sites and Clinical Investigators

PennCare—Bala Cynwyd Medical Associates: Ronald Barg, MD; Nelima Kute, MD; David Lush, MD; Celeste Mruk, MD; Charles Orellana, MD; Gail Rudnitsky, MD (primary care providers); Angela Monroe (lifestyle coach); and Lisa Anderson (practice administrator).

PennCare—Internal Medicine Associates of Delaware County: David E Eberly, MD; Albert H Fink Jr, MD; Kathleen Malone, CRNP; Peter B Nonack, MD; Daniel Soffer, MD; John N Thurman, MD; and Marc J Wertheimer, M.D. (primary care providers); Barbara Jean Shovlin; Lanisha Johnson (lifestyle coaches); Jill Esrey (practice administrator).

PennCare—Internal Medicine Mayfair: Jeffrey Heit, MD; Barbara C Joebstl, MD; and Oana Vlad, MD (primary care providers); Rose Schneider; Tammi Brandley (lifestyle coaches); Linda Jelinski (practice administrator).

Penn Presbyterian Medical Associates: Joel Griska, MD; Karen J Nichols, MD; Edward G Reis, MD; James W Shepard, MD; and Doris Davis-Whitely, PA (primary care providers); Dana Tioxon (lifestyle coach); and Charin Sturgis (practice administrator).

PennCare—University City Family Medicine: Katherine Fleming, CRNP; Dana B Greenblatt, MD; Lisa Schaffer, DO; Tamara Welch, MD; and Melissa Rosato, MD (primary care providers); Eugonda Butts; Marta Ortiz; Marysa Nieves; and Alethea White (lifestyle coach); Cassandra Bullard (practice administrator).

PennCare—West Chester Family Practice: Jennifer DiMedio, CRNP; Melanie Ice, DO; Brandt Loev, DO; John S Potts, DO; and Christine Tressel, DO (primary care providers); Iris Perez; Penny Rancy; Dianne Rittenhouse (lifestyle coaches); and Joanne Colligan (practice administrator).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadden, T., Volger, S., Sarwer, D. et al. Introduction to the POWER-UP supplement. Int J Obes 37 (Suppl 1), S1–S2 (2013). https://doi.org/10.1038/ijo.2013.89

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2013.89

Search

Quick links